📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

TriMaster: randomised double-blind crossover trial of a DPP4-inhibitor, SGLT2-inhibitor and thiazolidinedione to evaluate differential glycaemic response to therapy based on obesity and renal function (2022)

First Author: Hattersley A

Attributed to: Developing a decision support tool to enable precision treatment of type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-2132634/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-2132634/v1

Type: Preprint